letrozole
Showing 26 - 50 of 352
Breast Cancer Trial in Kansas City (Letrozole, Placebo)
Completed
- Breast Cancer
- Letrozole
- Placebo
-
Kansas City, KansasUniversity of Kansas Medical Center
Jan 9, 2022
Intrauterine Insemination, Unexplained Infertility Trial (Letrozole)
Not yet recruiting
- Intrauterine Insemination
- Unexplained Infertility
- Letrozole
- (no location specified)
Mar 7, 2022
Breast Tumor Female Trial in Melbourne (Venetoclax, Palbociclib, Letrozole)
Recruiting
- Breast Neoplasm Female
- Venetoclax
- +2 more
-
Melbourne, Victoria, Australia
- +2 more
Mar 10, 2022
Abortion in First Trimester Trial in Singapore (Letrozole, Mifepristone)
Not yet recruiting
- Abortion in First Trimester
- Letrozole
- Mifepristone
-
Singapore, SingaporeKK Women's and Children's Hospital
Apr 17, 2022
Metastatic or Locally-advanced Unresectable Breast Cancer Trial in New York (BYL719, Letrozole, Exemestane)
Completed
- Metastatic or Locally-advanced Unresectable Breast Cancer
- BYL719
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Mar 1, 2022
Endometrial Cancer Trial in Copenhagen (Palbociclib/, Letrozole)
Completed
- Endometrial Cancer
- Palbociclib/placebo
- Letrozole
-
Copenhagen, Sjaelland, DenmarkNSGO-CTU
Jan 7, 2022
Metastatic Breast Cancer, Unresectable Breast Cancer Trial in United States (Letrozole, Palbociclib, Onapristone ER)
Recruiting
- Metastatic Breast Cancer
- Unresectable Breast Cancer
- Letrozole
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Sep 12, 2022
Recurrent Endometrial Carcinoma, Recurrent Endometrial Endometrioid Adenocarcinoma, Refractory Endometrial Carcinoma Trial in
Recruiting
- Recurrent Endometrial Carcinoma
- +12 more
- Everolimus
- +2 more
-
Houston, Texas
- +1 more
Sep 22, 2022
Breast Tumors, Endocrine Breast Diseases, Tumor Metastasis Trial in Baltimore (letrozole, lapatinib, everolimus)
Terminated
- Breast Neoplasms
- +2 more
- letrozole
- +2 more
-
Baltimore, MarylandUniversity of Maryland Marlene & Stewart Greenebaum Cancer Cente
Feb 9, 2022
Breast Cancer Trial in United States (Letrozole, Ribociclib, Placebo)
Active, not recruiting
- Breast Cancer
- Letrozole
- +2 more
-
Little Rock, Arkansas
- +12 more
Sep 24, 2022
Obesity Trial in Ghent (Letrozole, Placebo)
Completed
- Obesity
- Letrozole
- Placebo
-
Ghent, BelgiumGhent University Hospital
Jan 21, 2022
Neoadjuvant Operable Breast Cancer Trial in Paris, Villejuif (Fluorouracile, Epirubicin, Cyclophosphamide)
Completed
- Neoadjuvant Operable Breast Cancer
- Fluorouracile
- +4 more
-
Paris, France
- +1 more
Mar 14, 2022
Polycystic Ovary Syndrome Trial in Multan (Letrozole)
Completed
- Polycystic Ovary Syndrome
- Letrozole
-
Multan, Punjab, PakistanNishtar Medical University Hospital
Oct 12, 2021
Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer Trial in Hong Kong, Japan, Singapore (LEE011, Letrozole,
Completed
- Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer
- LEE011
- +4 more
-
Hong Kong, Hong Kong
- +14 more
Oct 25, 2022
Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Invasive Ductal Breast Carcinoma Trial in Boston,
Active, not recruiting
- Estrogen Receptor-positive Breast Cancer
- +5 more
- PI3K inhibitor BYL719
- +3 more
-
Boston, Massachusetts
- +1 more
Oct 14, 2022
Metastatic Breast Cancer Trial in Springfield, Rochester, Lebanon (17B-estradiol, Letrozole, Anastrozole)
Active, not recruiting
- Metastatic Breast Cancer
- 17B-estradiol
- +3 more
-
Springfield, Massachusetts
- +2 more
Nov 1, 2022
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial
Active, not recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +20 more
- Hydroxychloroquine
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 12, 2022
Anovulation Trial in Toronto (Letrozole)
Completed
- Anovulation
- Letrozole
-
Toronto, Ontario, Canada
- +1 more
Sep 12, 2021
ART Trial in Assiut (Letrozole, Menotropins, recombinant Follicular stimulating hormone)
Withdrawn
- ART
- Letrozole
- +2 more
-
Assiut, EgyptWomen Health Hospital - Assiut university
Nov 26, 2022
Breast Cancer Trial in Guangzhou (Everolimus, Letrozole, Fluorouracil)
Completed
- Breast Cancer
- Everolimus
- +4 more
-
Guangzhou, Guangdong, ChinaSun-Yat-Sen Memorial Hospital of Sun-Yat-Sen University
Sep 22, 2021